Drug Research
Istari Oncology Enters Into Manufacturing Agreement With FUJIFILM Diosynth...
FUJIFILM Diosynth Biotechnologies (FDB) and Istari Oncology announced that they have entered into an agreement for the manufacturing of Istari Oncology’s viral immunotherapy, PVSRIPO, currently...
Drug Research
Moderna Announces FDA Authorization of a Booster Dose of...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for emergency use a booster dose...
Drug Research
Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled...
Enesi Pharma has entered into an agreement with the US National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to test...
Drug Research
Silence and Hansoh partner to develop siRNA-based treatments
Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the former’s mRNAi GOLD...
Drug Research
Stevanato Group Wins Pharma Innovation Award For AI-ready Vision...
Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has been recognized as...
Drug Research
Enzolytics and Samsung Biologics Announce Development and Manufacturing Agreement...
Samsung Biologics , a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat...
Drug Research
Metrics Contract Services Enters Partnership to Develop Oncology Drug
Metrics Contract Services, the US-based contract pharmaceutical development and manufacturing division of Mayne Pharma, announced the signing of a development and manufacturing agreement with ESSA...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.